Skip to content

Mindfulness-Based Group Medical Visits for Persons With Chronic Low Back Pain: A Randomized Clinical Trial.

Natalia E. Morone, Keturah R Faurot, Janice M Weinberg, Kathleen McTigue, Isabel Roth, Jessica L Barnhill, Paula Gardiner, Holly N Thomas, Christine Lathren, Maria Gabriela Castro, Jose E Baez, Suzanne Lawrence, Elondra Harr, Nandie Elhadidy, Anna Marie White, Phuong Tra Nguyen, Graham A Dore, Ruth Rodriguez, Susan A Gaylord, Carol M. Greco

JAMA Internal Medicine June 29, 2026 DOI: 10.1001/jamainternmed.2026.2186 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Randomized clinical trial Peer reviewed
Sample size 451
Population Adults with chronic low back pain attending primary care clinics in Massachusetts, Pennsylvania, and North Carolina; mean age 52.1 years; 70.5% female
Intervention Telehealth-delivered mindfulness group medical visit program
Duration 8-week intervention with follow-up at 8 weeks, 6 months, and 12 months
Measures Pain, Enjoyment of Life and General Activity (PEG) scale
Topics Meditation
Keywords Humans Low back pain Pain measurement Treatment outcome Telemedicine Adult Middle aged Primary health care Female Chronic pain Shared medical appointments
Registration NCT04129450
Key findings A telehealth-delivered mindfulness group medical visit program produced statistically significant improvements in pain intensity and interference compared with usual care at 8 weeks, 6 months, and 12 months (between-group PEG differences of -0.89, -0.62, and -0.74 points, respectively), but these changes did not reach the prespecified 1-point minimal clinically important difference at any time point.

Abstract

Importance: Back pain is among the most common, disabling, and costly conditions managed in primary care in the US, but current treatment options often do not provide adequate relief. Mindfulness-based interventions have demonstrated effectiveness in individuals with chronic low back pain (CLBP); however, mindfulness remains underused in part because it is not integrated into most outpatient care models.

Objective: To assess whether persons with CLBP participating in a mindfulness group medical visit intervention experience significantly improved pain intensity and interference compared with those receiving usual care. Design, setting, and

Participants: This randomized clinical trial, Optimizing Pain Treatment in Medical Settings Using Mindfulness (OPTIMUM), using a pragmatic approach (designed to evaluate interventions under typical conditions of care) was conducted from May 7, 2021, to November 6, 2024. Adults with CLBP attending primary care clinics in Massachusetts, Pennsylvania, and North Carolina were included. Intervention: Participants were randomized 1:1 to the OPTIMUM intervention, an 8-week telehealth-delivered mindfulness group medical visit program delivered as part of primary care (intervention), or usual care (controls).

Main Outcomes and Measures: The primary analysis assessed the between-group difference in the primary outcome of change from baseline to month 6 in the Pain, Enjoyment of Life and General Activity (PEG) scale score. A mean minimal clinically important difference (MCID) in PEG score of at least 1 was considered. Secondary analyses evaluated the between-group differences in change from baseline to week 8 and month 12 in PEG score.

Results: Of 451 participants (mean [SD], 52.1 [14.7] years; 318 [70.5%] female), 224 were randomized to the intervention group and 227 to the control group. All reported moderate pain interference at baseline. In intention-to-treat analyses, the intervention participants had a statistically significant improvement in PEG score from baseline compared with controls at the 6-month primary time point (mean change, -1.21 [95% CI, -1.50 to -0.92] vs -0.59 [95% CI, -0.86 to -0.31]; between-group difference, -0.62 [95% CI, -1.02 to -0.23]; P = .002) and at 8 weeks (mean change, -1.16 [95% CI, -1.44 to -0.88] vs -0.27 [95% CI, -0.53 to -0.003]; between-group difference, -0.89 [95% CI, -1.27 to -0.51]; P < .001) and 12 months (mean change, -1.52 [95% CI, -1.81 to -1.23] vs -0.78 [95% CI, -1.05 to -0.50]; between-group difference, -0.74 [95% CI, -1.14 to -0.34]; P < .001). The MCID was not met at any time point. Conclusions and relevance: In this randomized clinical trial, a telehealth-delivered mindfulness group medical visit program for persons with CLBP resulted in significant improvements in pain intensity and interference compared with usual care; however, these changes did not meet the prespecified mean 1-point MCID between groups. The program incorporated primary care clinicians, was accessible, and is potentially scalable as a nonpharmacologic treatment for CLBP.

Trial Registration: ClinicalTrials.gov Identifier: NCT04129450.

Comparable studies

Other randomized controlled trials on meditation, most cited first.

Study Year Design Participants
Alterations in Brain and Immune Function Produced by Mindfulness Meditation Healthy employees in a work environment 2003 Randomized controlled trial n = 41
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Recovered recurrently depressed patients 2000 Randomized controlled trial n = 145
Open hearts build lives: Positive emotions, induced through loving-kindness meditation, build consequential personal resources. Working adults 2008 Randomized controlled trial n = 139
Short-term meditation training improves attention and self-regulation Undergraduate Chinese students 2007 Randomized controlled trial n = 40
Mindfulness-Based Cognitive Therapy for Depression: Replication and Exploration of Differential Relapse Prevention Effects. Recovered recurrently depressed patients 2004 Randomized controlled trial n = 73

Citations in the library

Explore topics